Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab

PURPOSE: Previous reports have identified noninfectious uveitis as a potential sequela following both intravitreal bevacizumab and ranibizumab injections. We present two unique cases of acute anterior uveitis following intravitreal bevacizumab that did not occur with subsequent ranibizumab injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonopoulos, Christina, Stem, Maxwell, Comer, Grant M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236710/
https://www.ncbi.nlm.nih.gov/pubmed/22174573
http://dx.doi.org/10.2147/OPTH.S26880
Descripción
Sumario:PURPOSE: Previous reports have identified noninfectious uveitis as a potential sequela following both intravitreal bevacizumab and ranibizumab injections. We present two unique cases of acute anterior uveitis following intravitreal bevacizumab that did not occur with subsequent ranibizumab injections. METHODS: Case report. CONCLUSION: These cases may reflect differences in the etiology of anterior uveitis following intravitreal bevacizumab and ranibizumab. Given these differences, it may be reasonable to offer ranibizumab to patients who have experienced presumed bevacizumab-induced anterior uveitis.

Ejemplares similares